JeanneE.AndersonMD

Oncology • Anchorage, AK

Physician

Join to view full profile

Are you Dr. Anderson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
3851 Piper St
Ste U340
Anchorage, AK 99508
Phone+1 907-562-0321

Fax+1 907-562-2683

Summary

Dr. Jeanne Anderson, MD is an oncologist in Anchorage, Alaska. She is currently licensed to practice medicine in Alaska, Texas, and Washington. She is affiliated with Providence Alaska Medical Center and Alaska Regional Hospital.

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1991 - 1994
University of WashingtonResidency, Internal Medicine, 1989 - 1991
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1988 - 1989
Stanford University School of MedicineClass of 1988

Certifications & Licensure

AK State Medical License 2001 - 2024
WA State Medical License 1990 - 2003
TX State Medical License 1998 - 2001

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013

Clinical Trials

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia Start of enrollment: 2000 Feb 01
Completed
Phase 3
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis Start of enrollment: 2000 May 01
Completed
Phase 2
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer Start of enrollment: 2008 Apr 23
Completed
Phase 2
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Start of enrollment: 2009 Sep 01
Recruiting
Phase 3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

24 citations
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by ...
Lynn Symonds, Hannah M. Linden, Vijayakrishna K. Gadi, Larissa A. Korde, Eve T. Rodler
Clinical Breast Cancer. 2019-04-01
9 citations
Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.
Megan Othus, Elihu H. Estey, Guillermo Garcia-Manero, Brent L. Wood, Derek L. Stirewalt
Leukemia. 2019-02-01
2 citations
Pillars article: Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. The Lancet. 1972. 300: 1067-1069.
Eloise R. Giblett, Jeanne E. Anderson, Flossie Cohen, Bernard Pollara, Hilaire J. Meuwissen
Journal of Immunology. 2012-02-01